[Reported practices of antimicrobial use for upper respiratory tract infections]

Lutfi Jaber1, Orly Aromano-Zelekha, Shmuel Rigler

  • 1The Bridge to Peace Community Pediatric Center, Taibe, Israel. jabe@bezeqint.net

Harefuah
|April 23, 2005
PubMed
Abstract

Insights

Physician antibiotic prescribing for pediatric respiratory infections deviates from guidelines. Interventions are needed to promote appropriate antibiotic use in Israel.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial stewardship
  • General practice

Context:

  • Antibiotic resistance is a growing global health concern.
  • Guidelines exist for appropriate antibiotic prescribing in children.
  • Physician prescribing habits may not align with current evidence-based recommendations.

Purpose:

  • To assess pediatrician and family physician antibiotic prescribing practices for pediatric upper respiratory tract infections (URTIs).
  • To compare reported practices with Centers for Disease Control and Prevention (CDC) guidelines.

Summary:

  • A survey of 81 physicians revealed significant discrepancies between reported practices and recommendations.
  • Common issues included prescribing antibiotics for bronchitis and the common cold, and not adhering to diagnostic criteria for pharyngitis and sinusitis.
  • Many physicians initiated antibiotics before test results were available.

Impact:

  • Physician prescribing patterns for pediatric URTIs in Israel are not fully aligned with established guidelines.
  • There is a need for targeted interventions to improve judicious antibiotic prescribing among healthcare providers.
  • Optimizing antibiotic use can help combat antimicrobial resistance and improve patient outcomes.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...